Olivia. Osborn, et.al., Metabolic characterization of a mouse deficient in all known leptin receptor isoforms., Cellular and molecular neurobiology, 2010, 30

http://rdf.ncbi.nlm.nih.gov/pubmed/19582570

Olivia. Osborn, et.al., Metabolic characterization of a mouse deficient in all known leptin receptor isoforms., Cellular and molecular neurobiology, 2010, 30

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Lepr<m5Btlr>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4839995

class

http://purl.org/net/cito/citesAsAuthority

• Lepr<m5Btlr>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4839995

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased body weight_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0001260C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• decreased carbon dioxide production_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0008964C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• increased liver weight_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0002981C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• decreased respiratory quotient_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0010379C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• impaired glucose tolerance_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0005293C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• impaired glucose tolerance_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0005293B6BKSDLeprdbJLeprdbLeprdbLeprdb
• insulin resistance_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0005331C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• increased mesenteric fat pad weight_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0009298C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• increased omental fat pad weight_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0010045C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• decreased oxygen consumption_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0005290C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• hypoactivity_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0001402B6BKSDLeprdbJLeprdbLeprdbLeprdb
• increased total body fat amount_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0010024C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• decreased oxygen consumption_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0005290B6BKSDLeprdbJLeprdbLeprdbLeprdb
• abnormal response/metabolism to endogenous compounds_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0003638B6BKSDLeprdbJLeprdbLeprdbLeprdb
• increased brown adipose tissue amount_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0000005C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• hypoactivity_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0001402C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• decreased carbon dioxide production_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0008964B6BKSDLeprdbJLeprdbLeprdbLeprdb
• obese_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0001261C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• abnormal response/metabolism to endogenous compounds_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0003638C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• increased circulating insulin level_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0002079C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• abnormal circadian temperature homeostasis_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0011020C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• insulin resistance_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0005331B6BKSDLeprdbJLeprdbLeprdbLeprdb
• decreased body temperature_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0005534B6BKSDLeprdbJLeprdbLeprdbLeprdb
• abnormal eating behavior_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0001431C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr
• increased circulating leptin level_Lepr<m5Btlr>/Lepr<m5Btlr>
  http://metadb.riken.jp/0005669C57BL6Leprm5BtlrLeprm5BtlrLeprm5BtlrLeprm5Btlr